Tag: Neural network

Browse our exclusive articles!

Russia’s Sberbank Launches GigaChat to Compete with Microsoft ChatGPT and Google Bard

Sberbank, a Russian financial giant and one of the six largest banks in the world, has launched GigaChat - a top-of-the-line generative AI chatbot set to compete with industry leaders like Microsoft's ChatGPT and Google's Bard. Offering multimodal interaction in Russian and an open architecture to experiment with its features, GigaChat entrusts users with a host of functions - from responding to questions and conversing to writing code and generating images and texts from a single context. Join the invite-only testing phase to experience the ultimate AI functionality!

Enhancing GPT-4 and GPT-5 Using Hybrid AI to Address LLM Concerns

. OpenAI, founded by tech influencers Sam Altman and Greg Brockman, is developing powerful AI models, such as GPT-5, and exploring a hybrid AI model to combine connectionist and symbolic capabilities. With new plug-ins for ChatGPT, OpenAI could potentially take AI regulation and risk mitigation one step further. Get the inside scoop on OpenAI and the AI regulation conversation here!

Elon Musk To Launch ChatGPT Rival After Taking Credit for Original: ‘I Came Up With the Name’ (Video)

Elon Musk, the CEO of Tesla and Twitter, has announced his entrance in the AI chatbot industry by creating his own version of the popular OpenAI ChatGPT. Dubbed “TruthGPT”, the AI chatbot is designed with the aim of understanding the universe and understanding truth. With competition from Google’s DeepMind and Ilya Sutskever, Musk seeks to create a third option. Concerned with misuse of the technology, Musk proposed a moratorium on AI research and development. Experience these controversies and more with the AI ChatGPT software from Open AI.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img